Sensus Healthcare, Inc.: 10-Q filed 2020-11-10
What Sensus Healthcare, Inc. reported in its quarterly report filed 2020-11-10 (fiscal Q3 2020): 40 published measures, 115 facts as tagged in accession 0001213900-20-036128.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-11-10
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001213900-20-036128 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sensus Healthcare, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 27,721,217 | USD | |
| At 2019-12-31 | 36,924,547 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 7,306,586 | USD | |
| At 2019-12-31 | 8,923,125 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 20,414,631 | USD | |
| At 2020-06-30 | 22,069,736 | USD | |
| At 2020-03-31 | 24,566,956 | USD | |
| At 2019-12-31 | 28,001,422 | USD | |
| At 2019-09-30 | 26,812,221 | USD | |
| At 2019-06-30 | 27,384,470 | USD | |
| At 2019-03-31 | 27,195,430 | USD | |
| At 2018-12-31 | 26,460,016 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 16,127,085 | USD | |
| At 2019-12-31 | 8,100,288 | USD | |
| At 2019-09-30 | 6,905,547 | USD | |
| At 2018-12-31 | 12,484,256 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,692,253 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -7,853,941 | USD | 274 |
| 2020-04-01 to 2020-06-30 | -2,574,582 | USD | 91 |
| 2020-01-01 to 2020-03-31 | -3,587,106 | USD | 91 |
| 2019-07-01 to 2019-09-30 | -730,394 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -2,739,104 | USD | 273 |
| 2019-04-01 to 2019-06-30 | 112,308 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -2,121,018 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -73,761 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -2,566,572 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 254,863 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 542,484 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,620,163 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 4,482,557 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 5,840,945 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 18,753,839 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 966,014 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 2,620,484 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 7,134,544 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -5,632,621 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | -23,079,476 | USD | |
| At 2019-12-31 | -15,225,535 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 0 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 0 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,458,908 | USD | |
| At 2019-12-31 | 1,082,428 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 37,148 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 323,920 | USD | 274 |
| 2020-04-01 to 2020-06-30 | 130,994 | USD | 91 |
| 2020-01-01 to 2020-03-31 | 155,779 | USD | 91 |
| 2019-07-01 to 2019-09-30 | 158,145 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 470,825 | USD | 273 |
| 2019-04-01 to 2019-06-30 | 158,145 | USD | 91 |
| 2019-01-01 to 2019-03-31 | 154,535 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -2,279,404 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -8,491,233 | USD | 274 |
| 2019-07-01 to 2019-09-30 | -805,130 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -2,952,682 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 24,640,712 | USD | |
| At 2019-12-31 | 34,003,170 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 2,578 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 17,023 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 4,761,775 | USD | |
| At 2019-12-31 | 6,468,311 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 369,201 | USD | |
| At 2019-12-31 | 337,351 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,337,768 | USD | |
| At 2019-12-31 | 14,011,180 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 2,951,781 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 10,511,766 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 4,648,964 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 15,051,686 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 5,284,675 | USD | |
| At 2019-12-31 | 2,997,120 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 672,377 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 2,020,533 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 3,843,834 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 12,099,004 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 941,735 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 3,315,245 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 1,567,634 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,467,947 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 16,502,353 | shares | |
| At 2019-12-31 | 16,485,780 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,150,902 | USD | |
| At 2019-12-31 | 1,400,037 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,189,044 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,095,845 | USD | |
| At 2019-12-31 | 2,312,696 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,636,937 | USD | |
| At 2019-12-31 | 1,230,268 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 369,201 | USD | |
| At 2019-12-31 | 337,351 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 87,727 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,891,184 | USD | |
| At 2019-12-31 | 1,505,175 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 975,876 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 3,209,536 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 957,184 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 2,933,985 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 155,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 407,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 110,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 343,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 483,789 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 415,126 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 29,000 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 77,000 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 24,000 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 72,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 587,151 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 637,292 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 74,736 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 213,578 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 12,456 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -12,687,895 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 344,703 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 2,287,555 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 679,972 | USD | 273 |
Inspect the source
- Entity
- Sensus Healthcare, Inc. / CIK 0001494891
- Captured
- 2026-09-20T09:10:33.232Z
- SEC response SHA-256
577f11612f03de61036e40dc20e9a1fcbb190f3ed778f975b1fe0b4af3b4547b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001494891.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))